Study guide

12.5 Toxicology & Poisoning Management

APC Intern Written Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals

2 Legal Framework: PBS & Medicine Schedules

2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)

3 Legal Framework: Privacy, National Law & Pharmacy Board

3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards

4 Patient-Centred Medication Management

4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management

5 Primary Care & Judicious Use of Medicines

5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices

6 Dispensing & Clinical Appropriateness

6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes

7 Counselling & Acute Care

7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response

8 Therapeutics: Cardiovascular & Endocrine

8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders

9 Therapeutics: Infection, Respiratory & Gastrointestinal

9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health

10 Therapeutics: Neurology, Psychiatry & Pain

10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics

11 Therapeutics: Special Populations & Systems

11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment

12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology

12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management

13 Monitoring: Clinical Review

13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications

14 Monitoring: Safety & Adverse Drug Reactions

14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring

15 Compounding Medicines

15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations

16 Pharmaceutical Calculations

16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations

17 Promote Health & Well-Being

17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency

12.5 Toxicology & Poisoning Management

Key Takeaways Explain This Topic AI

The Australian Poisons Information Centre is 13 11 26, available 24 hours a day from anywhere in Australia; call 000 first if the person is unconscious, seizing, not breathing or anaphylactic.

Paracetamol poisoning is typically asymptomatic early, is assessed on a timed plasma concentration from four hours after acute ingestion, and is treated with acetylcysteine.

From 1 February 2025 general sale paracetamol packs are limited to 16 tablets, Schedule 2 packs to 50, and packs up to 100 became Pharmacist Only, with blister packaging required.

Take-home naloxone is supplied free and without a prescription through participating Australian pharmacies, and recipients must be told it wears off before most opioids do.

Inducing vomiting is obsolete and unsafe, and activated charcoal is a clinical decision made in a healthcare setting, not an over-the-counter recommendation.

Last updated: August 2026

12.5 Toxicology & Poisoning Management

Quick Answer: APC names toxicology as an exam content area. The pharmacist-level skills are knowing that the Poisons Information Centre is 13 11 26 , available 24 hours a day from anywhere in Australia; recognising when to call 000 instead; understanding that paracetamol toxicity is silent early; knowing take-home naloxone; and preventing poisoning through packaging, storage and disposal advice.

Poisoning presents to pharmacies constantly — a toddler who found a handbag, an older person who took a double dose, a distressed adult who has taken tablets, a person who mixed two cold-and-flu products. Standard 3.2 covers your acute response and Standard 3.3 covers recognising toxicity in ongoing therapy.

The two numbers you must know

Situation Call

The person is unconscious, not breathing, having a seizure, has collapsed, or has signs of anaphylaxis 000 immediately

Any other suspected poisoning, overdose, medication error or exposure Poisons Information Centre 13 11 26 — 24 hours a day, 7 days a week, anywhere in Australia

The Poisons Information Centre advises the public and provides toxicology advice to health professionals. Calling it is not an admission of ignorance; it is the correct professional action, and it is the answer that scores marks in an exam scenario about an uncertain ingestion.

Structured risk assessment

Before you advise anything, gather:

  • Agent — the exact product, active ingredients and strength; get the pack if possible
  • Dose — how much, using worst-case assumptions when the amount is uncertain
  • Time — when the exposure occurred, and whether it was a single event or repeated
  • Patient — age, weight, pregnancy, comorbidities, renal and hepatic function, other medicines
  • Intent — accidental, therapeutic error, or deliberate self-harm

Any deliberate self-poisoning requires medical assessment regardless of the dose taken , because the psychosocial risk is the reason for referral, not just the pharmacology. Respond without judgement, keep the person safe, and arrange assessment.

What not to do

Do not induce vomiting. Ipecac is obsolete and can cause harm.

Do not give activated charcoal on your own initiative. It is a clinical decision with a narrow time window and real aspiration risk, made in a healthcare setting.

Do not routinely give milk, water or food without advice — it can be wrong for corrosives and some agents.

Do not reassure on the basis of how well the person looks. Several important poisonings are asymptomatic for hours.

Paracetamol — the poisoning pharmacists meet most

Paracetamol is the medicine most often responsible for poisoning hospital admissions in Australia. Key teaching:

Early symptoms are absent or trivial — nausea at most. A patient who "feels fine" four hours after a large ingestion may still be heading for liver failure.

Assessment uses a timed plasma paracetamol concentration , typically from four hours after an acute ingestion, interpreted against a treatment nomogram. Staggered or repeated supratherapeutic ingestion cannot be assessed by the nomogram and needs direct clinical assessment.

The antidote is acetylcysteine (N-acetylcysteine) , most effective when started early. Never delay referral to "see how they go".

Risk is increased by chronic alcohol use, malnutrition, low body weight, and enzyme-inducing medicines.

Modified-release paracetamol overdose behaves differently from immediate-release and requires specialist toxicology advice.

The 2025 pack-size changes are exam-relevant

From 1 February 2025 , Australia tightened paracetamol availability to reduce overdose harm:

Non-pharmacy retailers such as supermarkets and convenience stores may sell packs of no more than 16 tablets or capsules

  • Pharmacy Medicine (Schedule 2) packs are limited to 50 tablets or capsules
  • Larger packs, up to 100, became Pharmacist Only (Schedule 3) and require pharmacist involvement
  • Blister packaging is required for tablets and capsules

This is a live example of scheduling changing to manage a toxicological risk, and it links directly to the Schedule 2 and 3 material in Chapter 2.

Opioid overdose and take-home naloxone

Recognise the triad: reduced consciousness, slow or absent breathing, and pinpoint pupils . Call 000 , support the airway, and give naloxone if available.

Australia's Take Home Naloxone program supplies naloxone free and without a prescription through participating pharmacies to anyone who may experience or witness an opioid overdose. Offer it proactively when supplying higher-dose opioids, when a person uses opioids with benzodiazepines or alcohol, after a period of abstinence when tolerance has fallen, and to family members. Counsel that naloxone is shorter acting than most opioids , so the person must still go to hospital even if they wake up.

Toxidromes worth recognising

Toxidrome Typical picture Common causes

Anticholinergic Hot, dry, flushed skin; dilated pupils; confusion; urinary retention; tachycardia Sedating antihistamines, tricyclics, oxybutynin, some plants

Serotonin toxicity Agitation, clonus, hyperreflexia, tremor, fever Combinations of SSRIs/SNRIs with tramadol, triptans, St John's wort, MAOIs

Opioid Sedation, respiratory depression, pinpoint pupils Opioids, often with alcohol or benzodiazepines

Sympathomimetic Agitation, sweating, tachycardia, hypertension, dilated pupils Stimulants, high-dose decongestants

Cholinergic Salivation, lacrimation, urination, diarrhoea, bradycardia Organophosphates, excess anticholinesterase therapy

Narrow therapeutic index medicines

Some medicines poison patients at doses close to their therapeutic range, which is why they carry monitoring requirements: lithium , digoxin , warfarin , phenytoin , theophylline , methotrexate and aminoglycosides . Dehydration, an added interacting medicine or a decline in renal function can convert a stable regimen into a toxic one without any change in the prescribed dose. Recognising that pathway is a Standard 3.3 skill.

Poisoning prevention — the pharmacist's daily contribution

Child-resistant closures and advice to keep medicines up high, locked and out of sight, including handbags and bedside tables

Oral dosing devices supplied and demonstrated — never a kitchen teaspoon

Counselling on maximum daily doses and on hidden duplicate ingredients in combination cold-and-flu products, which is a leading cause of accidental paracetamol excess

Encouraging return of unwanted and expired medicines to a community pharmacy through the national Return Unwanted Medicines (RUM) project rather than bins or the toilet

  • Reviewing dose administration aids for people at risk of confusion or double-dosing
  • Exam mindset

Toxicology stems reward decisive, correct escalation. Know 13 11 26 and when 000 comes first, never induce vomiting, never reassure on appearance after a paracetamol ingestion, offer take-home naloxone before you are asked, and remember that deliberate ingestion always needs assessment regardless of dose.